Molecular Partners to Present at 41st Annual JP Morgan Healthcare Conference and Swiss Investor ConferencesGlobeNewsWire • 12/30/22
Molecular Partners Presents New Preclinical Data Supporting its MP0533 DARPin T-Cell Engager for the Treatment of AMLGlobeNewsWire • 12/13/22
Molecular Partners Presents Positive Interim Safety and Mechanistic Data From Ongoing Phase 1 Trial of MP0317 for Treatment of Solid TumorsGlobeNewsWire • 11/10/22
Molecular Partners Announces Acceptance of Oral Presentation at the Annual American Society of Hematology MeetingGlobeNewsWire • 11/03/22
Molecular Partners Announces Upcoming Participation in Investor and Scientific ConferencesGlobeNewsWire • 11/02/22
Interim Management Statement Q3 2022: Continued Progress Across Oncology Programs with First Clinical Data Expected from Phase 1 Trial of MP0317 and Initiation of Phase 1 Trial of MP0533 Anticipated by Year-EndGlobeNewsWire • 10/27/22
Molecular Partners Class Action: Levi & Korsinsky Reminds Molecular Partners AG Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2022 - MOLNNewsfile Corp • 09/12/22
Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Molecular Partners AG (MOLN) Investors of Class Action and Last Few Hours to Actively ParticipateBusiness Wire • 09/12/22
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/12/22
MOLN FINAL DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLNNewsfile Corp • 09/12/22
FINAL INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the FirmBusiness Wire • 09/12/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Molecular Partners Investors of a Lead Plaintiff Deadline of September 12, 2022PRNewsWire • 09/12/22
SHAREHOLDER ALERT FILING DEADLINE ON MONDAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Molecular Partners AG of Class Action Lawsuit and Upcoming Deadline - MOLNNewsfile Corp • 09/10/22
DEADLINE MONDAY ALERT: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/09/22
MOLN SHAREHOLDER ALERT: Jakubowitz Law Reminds Molecular Partners Shareholders of a Lead Plaintiff Deadline of September 12, 2022PRNewsWire • 09/09/22
MOLN MONDAY DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors With Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLNNewsfile Corp • 09/08/22
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/08/22
MOLN LAWSUIT ALERT: Levi & Korsinsky Notifies Molecular Partners AG Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 09/08/22
MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/07/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Molecular Partners AG of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2022 - (NASDAQ: MOLN)PRNewsWire • 09/07/22
MOLN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2022 in the Class Action Filed on Behalf of Molecular Partners AG ShareholdersPRNewsWire • 09/06/22
Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Molecular Partners AG (MOLN) Investors of Class Action and to Actively ParticipateNewsfile Corp • 09/06/22
ROSEN, Leading Investor Counsel, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNNewsfile Corp • 09/03/22
